IRON:NASDAQ, Disc Medicine, Inc.

IRON stock overview

Disc Medicine, Inc. (IRON:NASDAQ) closed at $75.14 on November 20, 2026, down 1.27% on the day. The stock trades 24.5% below its 52-week high of $99.50 and 87.9% above its 52-week low of $40.00. Over the past year, it lost 20.2%. Disc Medicine, Inc. is part of the Health Care sector.

Key figures

Price
$75.14
Day change
-1.27%
Volume
561,636
Average volume
948,573
Market cap
3B+
52-week range
$40.00 – $99.50
50-day average
$71.61
200-day average
$70.89

Price action over the past year

In 252 trading sessions since November 20, 2025, IRON closed higher on 117 days (46%). Its best day was October 19, 2026 (+38.86%) and its worst was February 13, 2026 (-21.91%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

IRON news

About Disc Medicine, Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism.

Similar stocks

Find more stocks like IRON with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.